GlassScriptPhysician profile
Kenneth Douglas Shank
NPI 1083695159
$7,754.19
in general payments reported to CMS, 2019-2025
41 companies · $1,241 in 2025
The $1,241 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $774 · 2020: $965 · 2021: $796 · 2022: $1,110 · 2023: $1,306 · 2024: $1,562 · 2025: $1,241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,108.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,093.43 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $1,084.02 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $672.24 | 2019-2025 | |
| Abbvie INC. | $530.81 | 2021-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $506.91 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $483.89 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Exact Sciences Corporation | $392.70 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $385.49 | 2019-2025 | Otezla, Repatha, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $299.75 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $286.15 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $273.07 | 2019-2023 | |
| Abiomed | $161.36 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $159.54 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $144.96 | 2019-2025 | Eliquis |
| Xeris Pharmaceuticals, INC. | $138.76 | 2021-2024 | Gvoke Hypopen |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Shank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.